Dems pitch expanding Medicare power to negotiate drug prices

Reps.RichardNeal(D-Mass.),Rep.FrankPallone(D-N.J.),andRep.JohnYarmuth(D-Ky.)JoeRaedle/GettyImagesWAS DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio




knowledge

author：focus    Page View：19789

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. 

How do we ensure the population in a study best reflects the people who will get a medicine in the real world?

advertisement

STAT will bring together a panel of leading experts to discuss the best solutions-based approaches.

Featured speakers:

  • LaShell Robinson,senior director, head of diversity, equity & inclusion in clinical research, Takeda
  • Ramita Tandon, chief clinical trials officer, Walgreens
  • Vindell Washington, M.D., M.S., MS.c, chief clinical officer of care and director of Health Equity Center of Excellence, Verily
  • Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)
  • Jennifer Cullingford, vice president, customer success, OneStudyTeam (sponsor speaker)

Sponsored By

OneStudyTeam

 

Previous article： UHS says company favors patients whose insurance pays more
Next article： Duchenne breakthrough therapy leaves behind pioneering families